 Insmed Incorporated Nasdaq: INSM, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to 11 new employees. In accordance with NASDAQ Listing Rule 5635c4, the awards were approved by Insmeds Compensation Committee and made as a material inducement to each employees entry into employment with the Company. 